Healthcare provider profile · identity verified

Steven Anthony Patten, M.D.

Internal Medicine · TUCKER, GA · NPI 1457342693

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	415	121
Atorvastatin Calcium	Atorvastatin Calcium	404	118
Warfarin Sodium	Warfarin Sodium	377	263
Losartan Potassium	Losartan Potassium	223	63
Omeprazole	Omeprazole	202	68
Levothyroxine Sodium	Levothyroxine Sodium	201	44
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	199	69
Fluticasone Propionate	Fluticasone Propionate	191	85
Rosuvastatin Calcium	Rosuvastatin Calcium	188	61
Metformin Hcl	Metformin Hcl	180	50
Gabapentin	Gabapentin	164	63
Lisinopril	Lisinopril	149	46
Albuterol Sulfate Hfa	Albuterol Sulfate	131	49
Pantoprazole Sodium	Pantoprazole Sodium	112	36
Allopurinol	Allopurinol	108	26
Famotidine	Famotidine	96	25
Furosemide	Furosemide	93	32
Potassium Chloride	Potassium Chloride	89	31
Trazodone Hcl	Trazodone Hcl	87	32
Tamsulosin Hcl	Tamsulosin Hcl	84	23
Montelukast Sodium	Montelukast Sodium	83	28
Hydrochlorothiazide	Hydrochlorothiazide	81	27
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	78	39
Carvedilol	Carvedilol	76	22
Ozempic	Semaglutide	75	14
Metoprolol Succinate	Metoprolol Succinate	73	23
Jantoven	Warfarin Sodium	71	52
Alendronate Sodium	Alendronate Sodium	61	17
Metoprolol Tartrate	Metoprolol Tartrate	60	19
Naproxen	Naproxen	56	18
Mirtazapine	Mirtazapine	55	14
Hydralazine Hcl	Hydralazine Hcl	54	20
Jardiance	Empagliflozin	54	16
Azelastine Hcl	Azelastine Hcl	53	16
Pravastatin Sodium	Pravastatin Sodium	53	17
Escitalopram Oxalate	Escitalopram Oxalate	51	11
Meloxicam	Meloxicam	48	12
Eliquis	Apixaban	46	16
Sertraline Hcl	Sertraline Hcl	46	12
Amoxicillin	Amoxicillin	44	37
Nifedipine Er	Nifedipine	44	13
Simvastatin	Simvastatin	44	15
Atenolol	Atenolol	40	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	40	23
Dicyclomine Hcl	Dicyclomine Hcl	38	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	37	28
Clopidogrel	Clopidogrel Bisulfate	37	11
Donepezil Hcl	Donepezil Hcl	36	suppressed
Enoxaparin Sodium	Enoxaparin Sodium	34	27
Januvia	Sitagliptin Phosphate	34	suppressed
Colchicine	Colchicine	33	11
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	32	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	32	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	31	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	29	suppressed
Glipizide	Glipizide	29	11
Memantine Hcl	Memantine Hcl	29	suppressed
Tradjenta	Linagliptin	29	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	28	suppressed
Nebivolol Hcl	Nebivolol Hcl	27	suppressed
Meclizine Hcl	Meclizine Hcl	26	13
Pioglitazone Hcl	Pioglitazone Hcl	26	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	25	suppressed
Methylprednisolone	Methylprednisolone	24	23
Metoclopramide Hcl	Metoclopramide Hcl	24	suppressed
Vascepa	Icosapent Ethyl	23	suppressed
Cilostazol	Cilostazol	22	suppressed
Clonidine Hcl	Clonidine Hcl	22	suppressed
Ketoconazole	Ketoconazole	22	suppressed
Benztropine Mesylate	Benztropine Mesylate	21	suppressed
Diclofenac Sodium	Diclofenac Sodium	21	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	21	suppressed
Baclofen	Baclofen	20	suppressed
Breo Ellipta	Fluticasone/Vilanterol	20	suppressed
Ezetimibe	Ezetimibe	20	suppressed
Linzess	Linaclotide	20	suppressed
Valsartan	Valsartan	20	suppressed
Glipizide Er	Glipizide	19	suppressed
Ventolin Hfa	Albuterol Sulfate	19	suppressed
Glimepiride	Glimepiride	18	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	18	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	18	suppressed
Torsemide	Torsemide	18	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	18	suppressed
Citalopram Hbr	Citalopram Hydrobromide	17	suppressed
Labetalol Hcl	Labetalol Hcl	17	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	17	suppressed
Spironolactone	Spironolactone	17	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	17	17
Valacyclovir	Valacyclovir Hcl	17	12
Xarelto	Rivaroxaban	17	suppressed
Farxiga	Dapagliflozin Propanediol	16	suppressed
Fluconazole	Fluconazole	16	suppressed
Levetiracetam	Levetiracetam	16	suppressed
Nitroglycerin	Nitroglycerin	16	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	16	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	15	13
Ondansetron Odt	Ondansetron	15	suppressed
Selenium Sulfide	Selenium Sulfide	15	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	14	suppressed
Klor-Con M20	Potassium Chloride	14	suppressed
Tobramycin-Dexamethasone	Tobramycin/Dexamethasone	14	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	14	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	14	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	13	suppressed
Terazosin Hcl	Terazosin Hcl	13	suppressed
Amiodarone Hcl	Amiodarone Hcl	12	suppressed
Bupropion Xl	Bupropion Hcl	12	suppressed
Digoxin	Digoxin	12	suppressed
Duloxetine Hcl	Duloxetine Hcl	12	suppressed
Humulin N	Insulin Nph Human Isophane	12	suppressed
Levemir	Insulin Detemir	12	suppressed
Levemir Flexpen	Insulin Detemir	12	suppressed
Probenecid	Probenecid	12	suppressed
Amlodipine-Olmesartan	Amlodipine Bes/Olmesartan Med	11	suppressed
Azithromycin	Azithromycin	11	11
Doxycycline Hyclate	Doxycycline Hyclate	11	suppressed
Lidocaine	Lidocaine	11	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	11	suppressed
Propranolol Hcl Er	Propranolol Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error